Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02949219
Title Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Rapid City Regional Hospital Rapid City South Dakota 57701 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field